BRIEF-Madrigal Pharmaceuticals Q2 EPS USD -1.9

Reuters
Aug 05
BRIEF-Madrigal Pharmaceuticals <a href="https://laohu8.com/S/QTWO">Q2</a> EPS USD -1.9

Aug 05 (Reuters) - Madrigal Pharmaceuticals Q2 product revenue USD 212.802 million.

  • Q2 operating income USD -47.202 million
  • Q2 operating expenses USD 260.004 million
  • Q2 net income USD -42.281 million

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10